Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesIs severe epistaxis associated with acetylsalicylic acid intake
The Laryngoscope, 11/03/09
Soyka MB et al. – The authors not only identified ASA to be one of the major risk factors in epistaxis, but also quantified its impact on the severity of nose bleeding. We emphasize the importance of a well–indicated antiaggregational therapy, and strongly discourage using ASA as a life–style drug for the elderly. ASA therapy needs to be discontinued whenever possible and reasonable.
Related Articles
Characterization of initial clinical symptoms and risk factors for sinonasal adenocarcinomas: results of a case-control study
International Archives of Occupational & Environmental Health, 11/06/09
Relevance Score: 80%
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09
Relevance Score: 77%
Endovascular embolization with a vascular plug corrects a PAVM
JAAPA, 10/26/09
Relevance Score: 77%
Today in ENT...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical Outcome in Patients with Oral Verrucous Carcinoma: Long-Term Follow-Up in an Endemic Betel Quid Chewing Area
Journal for Oto-Rhino-Laryngology, 12/18/09
Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence
Clinical Otolaryngology, 12/18/09
Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy
Clinical Otolaryngology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor